- 5 Results
Lowest price: € 76.99, highest price: € 200.35, average price: € 156.62
1
Cancer Immunology and Immunotherapy | Glenn Dranoff | Buch | Current Topics in Microbiology and Immunology | HC runder Rücken kaschiert | XIV | Englisch | 2011 | Springer-Verlag GmbH - Dranoff, Glenn
Order
at booklooker.de
€ 182.50
Shipment: € 0.001
Order
Provider details
Sponsored link
Dranoff, Glenn:

Cancer Immunology and Immunotherapy | Glenn Dranoff | Buch | Current Topics in Microbiology and Immunology | HC runder Rücken kaschiert | XIV | Englisch | 2011 | Springer-Verlag GmbH - hardcover

2011, ISBN: 9783642141355

[ED: Gebunden], [PU: Springer-Verlag GmbH], The interplay between tumors and their immunologic microenvironment is complex, difficult to decipher, but its understanding is of seminal impo… More...

Shipping costs:Versandkostenfrei, Versand nach Deutschland. (EUR 0.00) preigu
close (x)
2
Cancer Immunology and Immunotherapy (Current Topics in Microbiology and Immunology, 344, Band 344)
Order
at Amazon.de (Intern. Bücher)
€ 198.80
Shipment: € 3.001
Order
Provider details
Sponsored link
Cancer Immunology and Immunotherapy (Current Topics in Microbiology and Immunology, 344, Band 344) - hardcover

2011, ISBN: 9783642141355

Springer, Gebundene Ausgabe, Auflage: 2011, 320 Seiten, Publiziert: 2011-04-15T00:00:01Z, Produktgruppe: Buch, 1.43 kg, Immunsystem, Körperteile, Medizin, Kategorien, Bücher, Onkologie & … More...

Shipping costs:Die angegebenen Versandkosten können von den tatsächlichen Kosten abweichen. (EUR 3.00)
close (x)
3
Cancer Immunology and Immunotherapy (Current Topics in Microbiology and Immunology, 344, Band 344)
Order
at Amazon.de (Intern. Bücher)
€ 200.35
Shipment: € 3.001
Order
Provider details
Sponsored link
Cancer Immunology and Immunotherapy (Current Topics in Microbiology and Immunology, 344, Band 344) - hardcover

2011

ISBN: 9783642141355

Springer, Gebundene Ausgabe, Auflage: 2011, 320 Seiten, Publiziert: 2011-04-15T00:00:01Z, Produktgruppe: Buch, 1.43 kg, Immunsystem, Körperteile, Medizin, Kategorien, Bücher, Onkologie & … More...

Shipping costs:Gewöhnlich versandfertig in 2 bis 3 Tagen. Die angegebenen Versandkosten können von den tatsächlichen Kosten abweichen. (EUR 3.00) buchbaer
close (x)
4
Cancer Immunology and Immunotherapy (Current Topics in Microbiology and Immunology, 344, Band 344)
Order
at Amazon.de (Intern. Bücher)
€ 76.99
Shipment: € 3.001
Order
Provider details
Sponsored link
Cancer Immunology and Immunotherapy (Current Topics in Microbiology and Immunology, 344, Band 344) - hardcover

2011, ISBN: 9783642141355

Springer, Gebundene Ausgabe, Auflage: 2011, 320 Seiten, Publiziert: 2011-04-15T00:00:01Z, Produktgruppe: Buch, 1.43 kg, Immunsystem, Körperteile, Medizin, Kategorien, Bücher, Onkologie & … More...

Shipping costs:Gewöhnlich versandfertig in 6 bis 7 Tagen. Die angegebenen Versandkosten können von den tatsächlichen Kosten abweichen. (EUR 3.00) Paper Cavalier Deutschland
close (x)
5
Cancer Immunology and Immunotherapy (Current Topics in Microbiology and Immunology, 344) - Dranoff, Glenn
Order
at AbeBooks.de
€ 124.45
Shipment: € 30.901
Order
Provider details
Sponsored link
Dranoff, Glenn:
Cancer Immunology and Immunotherapy (Current Topics in Microbiology and Immunology, 344) - hardcover

2011, ISBN: 3642141358

[EAN: 9783642141355], Gebraucht, sehr guter Zustand, [PU: Springer], In Used Condition, Books

NOT NEW BOOK. Shipping costs: EUR 30.90 Byrd Books, Austin, TX, U.S.A. [83414208] [Rating: 5 (von 5)]
close (x)
1As some platforms do not transmit shipping conditions to us and these may depend on the country of delivery, the purchase price, the weight and size of the item, a possible membership of the platform, a direct delivery by the platform or via a third-party provider (Marketplace), etc., it is possible that the shipping costs indicated by find-more-books.com / find-more-books.com do not correspond to those of the offering platform.

Bibliographic data of the best matching book

Details of the book
Cancer Immunology and Immunotherapy (Current Topics in Microbiology and Immunology, 344, Band 344)
Author:
Title:
ISBN:

9783642141355


The interplay between tumors and their immunologic microenvironment is complex, difficult to decipher, but its understanding is of seminal importance for the development of novel prognostic markers and therapeutic strategies. The present review discusses tumor-immune interactions in several human cancers that illustrate various aspects of this complexity and proposes an integrated scheme of the impact of local immune reactions on clinical outcome. Current active immunotherapy trials have shown durable tumor regressions in a fraction of patients. However, clinical efficacy of current vaccines is limited, possibly because tumors skew the immune system by means of myeloid-derived suppressor cells, inflammatory type 2 T cells and regulatory T cells (Tregs), all of which prevent the generation of effector cells. To improve the clinical efficacy of cancer vaccines in patients with metastatic disease, we need to design novel and improved strategies that can boost adaptive immunity to cancer, help overcome Tregs and allow the breakdown of the immunosuppressive tumor microenvironment.

Details of the book - Cancer Immunology and Immunotherapy (Current Topics in Microbiology and Immunology, 344, Band 344)


EAN (ISBN-13): 9783642141355
ISBN (ISBN-10): 3642141358
Hardcover
Publishing year: 2011
Publisher: Dranoff, Glenn, Springer
304 Pages
Weight: 0,605 kg
Language: eng/Englisch

Book in our database since 2007-11-22T16:26:21-05:00 (New York)
Detail page last modified on 2024-01-10T12:45:12-05:00 (New York)
ISBN/EAN: 9783642141355

ISBN - alternate spelling:
3-642-14135-8, 978-3-642-14135-5
Alternate spelling and related search-keywords:
Book author: dran
Book title: the topic cancer, cancer immunology immunotherapy, current topics microbiology and immunology, 344

Information from Publisher

Author: Glenn Dranoff
Title: Current Topics in Microbiology and Immunology; Cancer Immunology and Immunotherapy
Publisher: Springer; Springer Berlin
306 Pages
Publishing year: 2011-04-15
Berlin; Heidelberg; DE
Printed / Made in
Language: English
213,99 € (DE)
219,99 € (AT)
236,00 CHF (CH)
POD
XIV, 306 p.

BB; Hardcover, Softcover / Medizin/Nichtklinische Fächer; Onkologie; Verstehen; Medizin, Gesundheit; dendritic cells; immune infiltration; regulatory T cells; signal transducer and activator of transcription 3 (Stat3); tumor-immune interactions; Cancer Biology; Immunology; Immunologie; BC

The recent FDA approval of Provenge® as the first therapeutic cancer vaccine together with the recent demonstration that Ipilimumab®, a monoclonal antibody that blocks the negative immune checkpoint cytotoxic T lymphocyte associated antigen-4, prolongs patient survival are major achievements that usher in a new era of cancer immunotherapy. These “first-in-class” treatments reflect the substantive progress that basic and translational scientists have made towards understanding the mechanisms underlying protective tumor immunity in cancer patients Immunotherapies were first explored at the turn of the twentieth century, but the crafting of potent treatments required more detailed knowledge of how the immune system responds to cancer. Advances in genetic, cellular, and biochemical technologies have begun to yield this critical information, focusing attention on immune recognition, regulation, and escape. Indeed, the dynamic interplay of these processes in the tumor microenvironment is now recognized to play a decisive role in determining disease outcome. This volume highlights the rapid progress and breadth of research in cancer immunology, and provides a framework for anticipating many more clinical successes in cancer immunotherapy.
The interplay between tumors and their immunologic microenvironment is complex, difficult to decipher, but its understanding is of seminal importance for the development of novel prognostic markers and therapeutic strategies. The present review discusses tumor-immune interactions in several human cancers that illustrate various aspects of this complexity and proposes an integrated scheme of the impact of local immune reactions on clinical outcome. Includes supplementary material: sn.pub/extras
< to archive...